Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568723 · ClinicalTrials.gov registry record
Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 125
- Enrollment target
NCT01568723: Completed study, sponsored by Mayo Clinic.
NCT01568723 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01568723 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.
Interventions
- GENETIC response to therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2012-01 |
| Est. Completion | 2018-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568723
The ClinicalTrials.gov registry entry for NCT01568723 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which response to therapy is the first listed.
NCT01568723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568723 about?
NCT01568723 is a clinical study titled "Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation". The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.
What is the current status of trial NCT01568723?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2012-01. Estimated completion is 2018-08-16.
What interventions are being tested in trial NCT01568723?
The interventions under investigation include: response to therapy (GENETIC).
Who is sponsoring clinical trial NCT01568723?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.